Heterogeneity of abdominal obesity in patients with cardiovascular diseases
Open Access
- 12 January 2022
- journal article
- research article
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 17 (6), 867-872
- https://doi.org/10.20996/1819-6446-2021-12-17
Abstract
Aim: To assess the content of visceral adipose tissue (VAT) in patients with abdominal obesity and its relationship with metabolic disorders. Material and methods. Patients with abdominal obesity (n=107) were included in the study. All participants had an assessment of anthropometric parameters (height, weight), calculation of body mass index (BMI), proportion of total adipose tissue and VAT (bioimpedance analyzer), high-density lipoprotein cholesterol (HDL-c) levels, triglycerides, fasting blood glucose, epicardial thickness adipose tissue (two-dimensional echocardiography). Results. The median share of VAT (bioimpedance method) was 13%. Patients with abdominal obesity are divided by VAT into 2 groups: ≥14% or ≤13%. Patients with VAT≥14% had significantly higher levels of triglycerides (1.76 [1.27; 2.38] mmol / L) and glucose (6.33 [5.78; 7.87] mmol / L), and below HDL-c levels (0.95 [0.85; 1.21] mmol / L) compared with patients with VAT≤13% (1.32 [1.02; 1.50], 5.59 [5, 11; 6.16] and 1.31 [1.07; 1.58] mmol / L, respectively; pConclusion. Persons with abdominal obesity are heterogeneous in the proportion of VAT. The proportion of VAT above the median is associated with metabolic disorders that are significant for the development and progression of atherosclerosis. An increase in BMI in obese individuals is not associated with an increase in VAT and an increase in the severity of metabolic disorders.Keywords
This publication has 19 references indexed in Scilit:
- Metabolically Healthy Obesity and the Risk of Cardiovascular Disease in the Elderly PopulationPLOS ONE, 2016
- The methods for the characteristic of adipose tissue in the organism and their clinical significanceProblemy Endokrinologii, 2014
- The Concept of Normal Weight ObesityProgress in Cardiovascular Diseases, 2013
- Pathophysiology of Human Visceral Obesity: An UpdatePhysiological Reviews, 2013
- Performance of Bioelectrical Impedance Analysis in the Diagnosis of Metabolic SyndromeJournal of Investigative Medicine, 2012
- Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortalityEuropean Heart Journal, 2009
- Harmonizing the Metabolic SyndromeJournal of the American College of Cardiology, 2009
- Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US populationEuropean Heart Journal, 2008
- Diagnosis and Management of the Metabolic SyndromeJournal of the American College of Cardiology, 2005
- Epicardial Fat from Echocardiography: A New Method for Visceral Adipose Tissue PredictionObesity Research, 2003